Cochrane Database Syst Rev
July 2016
Background: Inflammation and oedema of the facial nerve are implicated in causing Bell's palsy. Corticosteroids have a potent anti-inflammatory action that should minimise nerve damage. This is an update of a review first published in 2002 and last updated in 2010.
View Article and Find Full Text PDFCochrane Database Syst Rev
November 2015
Background: Corticosteroids are widely used in the treatment of idiopathic facial paralysis (Bell's palsy), but the effectiveness of additional treatment with an antiviral agent is uncertain. Significant morbidity can be associated with severe cases of Bell's palsy. This review was first published in 2001 and revised several times, most recently in 2009.
View Article and Find Full Text PDFCochrane Database Syst Rev
July 2015
Background: Corticosteroids are widely used in the treatment of idiopathic facial paralysis (Bell's palsy), but the effectiveness of additional treatment with an antiviral agent is uncertain. Significant morbidity can be associated with severe cases of Bell's palsy.
Objectives: To assess the effects of antiviral treatments alone or in combination with any other therapy for Bell's palsy.
Cochrane Database Syst Rev
May 2015
Background: Corticosteroids are widely used in the treatment of idiopathic facial paralysis (Bell's palsy), but the effectiveness of additional treatment with an antiviral agent is uncertain. Significant morbidity can be associated with severe cases of Bell's palsy.
Objectives: To assess the effects of antiviral treatments alone or in combination with any other therapy for Bell's palsy.